Management of Hyperglycemia in Type 2 Diabetes: A Patient-Centered Approach
Authors
Discussion
Loading...
Member takes
Implication
Clinical guidance outlines individualized glucose-lowering options in type 2 diabetes mellitus, highlighting cellular mechanisms to optimize treatment.
Key Points
- To provide a patient-centered framework for selecting appropriate glucose-lowering therapies based on drug properties and cellular mechanisms.
- Reviewed and categorized currently available glucose-lowering drug classes and specific compounds.
- Assessed underlying cellular mechanisms and clinical characteristics to guide personalized agent selection.
- Different classes of glucose-lowering agents exert glycemic control through distinct cellular targets and biological pathways.
- Treatment strategies require aligning individual patient profiles and comorbidities with drug-specific mechanisms and potential adverse effects.
Cite This Study
Inzucchi et al. (2012) studied this question.